Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Robert Cook

1PUBLICATIONS

14CO-AUTHORS

Medical infection agents (incl. prions)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|May 07, 2025

A phase 1/2a clinical trial to assess safety and immunogenicity of an adenoviral-vectored capsular group B meningococcal vaccine.

Christina Dold, Blanché Oguti, Laura Silva-Reyes

Pageof 1

Frequent Collaborators

1 joint publications

Christina Dold

1 joint publications

Blanché Oguti

1 joint publications

Meriel Raymond

1 joint publications

Catherine C Smith

1 joint publications

Maria Moore

1 joint publications

Edward M Choi

1 joint publications

Kiarash Tanha

1 joint publications

Jessica King

1 joint publications

Jay Lucidarme

1 joint publications

Ray Borrow

Frequent Collaborators

1 joint publications

Christina Dold

1 joint publications

Blanché Oguti

1 joint publications

Meriel Raymond

1 joint publications

Catherine C Smith

Top Related Videos

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant <em>Staphylococcus aureus</em> (MRSA) Infection

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant <em>Staphylococcus aureus</em> (MRSA) Infection

Published on : Sep 01, 2023

See more related videos

Top Related Videos

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant <em>Staphylococcus aureus</em> (MRSA) Infection

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant <em>Staphylococcus aureus</em> (MRSA) Infection

Published on : Sep 01, 2023

See more related videos